RAINBOW.NS Profit & Loss
Rainbow Childrens Medicare Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:45
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹11.74 Bn | ₹12.97 Bn | ₹15.16 Bn | ₹17.03 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.31 Bn | ₹0.37 Bn | ₹0.51 Bn | ₹0.44 Bn | OtherIncome |
| Total Income | ₹12.04 Bn | ₹13.34 Bn | ₹15.67 Bn | ₹17.47 Bn | Income |
| Cost of Materials Consumed | ₹1.58 Bn | ₹1.65 Bn | ₹1.95 Bn | ₹2.27 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹1.44 Bn | ₹1.76 Bn | ₹2.06 Bn | ₹2.34 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.55 Bn | ₹0.59 Bn | ₹0.72 Bn | ₹0.78 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹0.90 Bn | ₹1.12 Bn | ₹1.38 Bn | ₹1.51 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹4.75 Bn | ₹5.27 Bn | ₹6.25 Bn | ₹6.98 Bn | OtherExpenses |
| Total Expenses | ₹9.23 Bn | ₹10.39 Bn | ₹12.37 Bn | ₹13.87 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹2.82 Bn | ₹2.95 Bn | ₹3.30 Bn | ₹3.60 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹-0.02 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹2.82 Bn | ₹2.95 Bn | ₹3.30 Bn | ₹3.58 Bn | ProfitBeforeTax |
| Tax Expense | ₹0.69 Bn | ₹0.77 Bn | ₹0.86 Bn | ₹0.77 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹2.12 Bn | ₹2.18 Bn | ₹2.44 Bn | ₹2.82 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹2.11 Bn | ₹2.17 Bn | ₹2.43 Bn | ₹2.78 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹20.89 | ₹21.38 | ₹23.97 | ₹27.41 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹20.89 | ₹21.38 | ₹23.84 | ₹27.41 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from RAINBOW.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).